High-Dose vs Standard-Dose Twice-Daily Thoracic Radiotherapy for Limited-Stage Small-Cell Lung Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
High-Dose Versus Standard-Dose Twice-Daily Thoracic Radiotherapy for Patients With Limited Stage Small-Cell Lung Cancer: An Open-Label, Randomised, Phase 2 Trial
Lancet Oncol 2021 Mar 01;22(3)321-331, BH Grønberg, KT Killingberg, Ø Fløtten, OT Brustugun, K Hornslien, T Madebo, SW Langer, T Schytte, J Nyman, S Risum, G Tsakonas, J Engleson, TO HalvorsenFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.